Effective June 1, 2025, employers that employ more than 100 employees at a single warehouse distribution center or more than 1,000 employees at one ...
Osteoarthritis (OA) is a condition that disproportionally affects postmenopausal women, and the millions affected can attest ...
Through the act, employers are required to correct any risk factors identified as having caused or being likely to cause musculoskeletal injuries and disorders in a timely manner. If the employer ...
Onabotulinumtoxin A is under clinical development by AbbVie and currently in Phase III for Unspecified Musculoskeletal Disorders. According to GlobalData, Phase III drugs for Unspecified ...
Incobotulinumtoxin A is under clinical development by Merz Therapeutics and currently in Phase II for Unspecified Musculoskeletal Disorders. According to GlobalData, Phase II drugs for Unspecified ...
Objectives To investigate the effect of precarious employment (PE) on the risk of diagnosed chronic musculoskeletal disorders (MSDs) among Swedish workers in occupations with strenuous working ...